Charles Schwab Investment Management Inc Cor Medix Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Cor Medix Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 177,188 shares of CRMD stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,188

Previous 174,418 1.59%

Holding current value

$2.1 Million

Previous $1.41 Million 22.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$6.16 - $12.57 $17,063 - $34,818	2,770 Added 1.59%	177,188 $1.09 Million
Q4 2024 Feb 06, 2025	BUY	$8.1 - $13.59 $144,738 - $242,839	17,869 Added 11.41%	174,418 $1.41 Million
Q2 2024 Aug 12, 2024	BUY	$4.08 - $6.39 $49,498 - $77,523	12,132 Added 8.4%	156,549 $677,000
Q1 2024 May 08, 2024	SELL	$2.94 - $4.24 $20,218 - $29,158	-6,877 Reduced 4.55%	144,417 $612,000
Q4 2023 Feb 06, 2024	BUY	$3.0 - $4.01 $24,120 - $32,240	8,040 Added 5.61%	151,294 $568,000
Q3 2023 Nov 08, 2023	BUY	$3.6 - $4.46 $67,143 - $83,183	18,651 Added 14.97%	143,254 $530,000
Q2 2023 Aug 09, 2023	BUY	$3.94 - $5.8 $401,876 - $591,594	101,999 Added 451.24%	124,603 $493,000
Q1 2023 May 11, 2023	BUY	$3.22 - $4.61 $27,872 - $39,904	8,656 Added 62.06%	22,604 $93,000
Q2 2022 Aug 15, 2022	SELL	$2.73 - $5.61 $231,345 - $475,402	-84,742 Reduced 85.87%	13,948 $57,000
Q1 2022 May 13, 2022	BUY	$3.83 - $6.24 $16,855 - $27,462	4,401 Added 4.67%	98,690 $541,000
Q2 2021 Aug 16, 2021	BUY	$6.05 - $10.09 $70,851 - $118,163	11,711 Added 14.18%	94,289 $647,000
Q1 2021 May 17, 2021	BUY	$6.84 - $17.58 $13,659 - $35,107	1,997 Added 2.48%	82,578 $825,000
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $54,115 - $99,030	10,823 Added 15.52%	80,581 $599,000
Q3 2020 Nov 13, 2020	BUY	$3.96 - $6.15 $26,951 - $41,856	6,806 Added 10.81%	69,758 $421,000
Q2 2020 Aug 14, 2020	BUY	$3.08 - $6.56 $9,424 - $20,073	3,060 Added 5.11%	62,952 $397,000
Q4 2019 Feb 07, 2020	BUY	$4.96 - $7.75 $24,358 - $38,060	4,911 Added 8.93%	59,892 $437,000
Q2 2019 Aug 09, 2019	BUY	$5.93 - $10.57 $326,037 - $581,149	54,981 New	54,981 $494,000

Others Institutions Holding CRMD

# of Institutions

153

Shares Held

22.9M

Call Options Held

475K

Put Options Held

777K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $488M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Cor Medix Inc. Transaction History